RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000077.xml
Semin Thromb Hemost 2013; 39(01): 112
DOI: 10.1055/s-0032-1333535
DOI: 10.1055/s-0032-1333535
Erratum
Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
Weitere Informationen
Address for correspondence and reprint requests
Erik Fung, MB, ChB, PhD
Section of Cardiology, Heart & Vascular Center
Dartmouth-Hitchcock Medical Center, One Medical Center Drive
Lebanon, New Hampshire 03756
eMail: erik.fung@hitchcock.org
Publikationsverlauf
Publikationsdatum:
31. Dezember 2012 (online)
The publisher regrets an error in a sentence in the above article in Seminars in Thrombosis & Hemostasis, Volume 38, Number 8, p. 900. The correct sentence is as below:
In the latest prospective, clinical effectiveness trial, pharmacogenetic guidance was found to decrease the OOR INR by 12%.17
#
Address for correspondence and reprint requests
Erik Fung, MB, ChB, PhD
Section of Cardiology, Heart & Vascular Center
Dartmouth-Hitchcock Medical Center, One Medical Center Drive
Lebanon, New Hampshire 03756
eMail: erik.fung@hitchcock.org